CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT MARKED [****] HAVE BEEN REDACTED AND HAVE BEEN FILED SEPARATELY WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION.Transition Services Agreement • March 10th, 2006 • Atherogenics Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 10th, 2006 Company Industry Jurisdiction
EXHIBIT 10.35 CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT MARKED [****] HAVE BEEN REDACTED AND HAVE BEEN FILED SEPARATELY WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • March 10th, 2006 • Atherogenics Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 10th, 2006 Company Industry Jurisdiction
ANDCo-Promotion Agreement • March 10th, 2006 • Atherogenics Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 10th, 2006 Company Industry Jurisdiction
EXHIBIT 10.34 CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN FILED SEPARATELY WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION COMMERCIAL SUPPLY AGREEMENTCommercial Supply Agreement • March 10th, 2006 • Atherogenics Inc • Pharmaceutical preparations • Michigan
Contract Type FiledMarch 10th, 2006 Company Industry Jurisdiction